Xenetic Biosciences Inc
NASDAQ:XBIO 3:59:45 PM EDT
| Market Cap (Intraday) | 26.87M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $3.36 |
| 50-Day MA | $2.26 |
| 200-Day MA | $2.05 |
Xenetic Biosciences Inc Stock, NASDAQ:XBIO
40 Speen Street, Suite 102, Framingham, Massachusetts 01701
United States of America
Phone: +1.781.778.7720
Number of Employees: 4
Description
Xenetic Biosciences, Inc. is a biopharmaceutical company, which engages in the advancement of cell-based therapeutics to target the B-cell receptor on the surface of an individual patient�s malignant tumor cells. Its product pipeline includes XCart Platform and Polyxen. The company was founded on August 9, 2011 and is headquartered in Framingham, MA.